AVAN

Avant Immunotherapeutics (MM) (AVAN)

Avant Immunotherapeutics (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AVAN

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2008/09/30	06 : 02	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Current report filing (8-K)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/30	00 : 43	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/30	00 : 42	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/30	00 : 42	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/30	00 : 42	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/30	00 : 41	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/30	00 : 41	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/29	21 : 00	Business Wire	AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/24	07 : 14	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/19	23 : 28	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/09/19	05 : 00	Business Wire	AVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/08/14	05 : 53	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/08/09	05 : 16	Business Wire	AVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth Conference	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/08/06	23 : 52	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Current report filing (8-K)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/08/06	21 : 46	Business Wire	CORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial Results	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/08/06	21 : 00	Business Wire	AVANT Reports Second Quarter and Six Month Financial Results	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/08/05	02 : 56	Business Wire	AVANT to Report Second Quarter 2008 Financial Results on August 6, 2008	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/07/29	06 : 25	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Current report filing (8-K)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/07/19	05 : 59	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Current report filing (8-K)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/07/19	03 : 05	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/27	05 : 47	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/19	00 : 13	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Securities Registration: Employee Benefit Plan (S-8)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/11	21 : 00	Business Wire	AVANT Announces Vaccine Adjuvant Licenses with 3M	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/10	05 : 29	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Current report filing (8-K)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/04	23 : 00	Business Wire	AVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/04	20 : 00	Business Wire	NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/03	21 : 30	Marketwired	Market Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN NACEL Energy Achieves Objectives With 640 MW Wind Power in De	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/03	05 : 56	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Current report filing (8-K)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/06/03	03 : 32	Marketwired	New Analyst Reports for AVANT IMMUNOTHERAPEUTICS, CANADIAN SOLAR INC, LIBERTY MEDIA HOLDING CORPORATION, and BED BATH AND BEYOND	NASDAQ:AVAN	Avant Immunotherapeutics (MM)
2008/05/31	02 : 54	Edgar (US Regulatory)	Avant Immunotherapeutics Inc - Current report filing (8-K)	NASDAQ:AVAN	Avant Immunotherapeutics (MM)